Xcout Intel
Character Biosciences competitors & alternatives
The 12 closest competitors and alternatives to Character Biosciences among biotech companies — ranked by similarity to what Character Biosciences actually does, not by market-cap band.
Subscribe to see Character Biosciences’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Character Biosciences
Character Biosciences is a biotechnology company that uses human genetics and functional genomics to discover and develop precision medicines. Its work has focused particularly on genetically informed therapies for age-related diseases, including ophthalmic conditions such as age-related macular degeneration.
Character Biosciences at a glance
Character Biosciences is a biotech company headquartered in United States. Its most recent funding round raised $8.9M in September 2025. Xcout tracks 18 named people at Character Biosciences, including Cheng Zhang (CEO, CFO, and Secretary). Xcout recorded 1 job posting from Character Biosciences in the last 90 days.
Character Biosciences leadership
- Cheng ZhangCEO, CFO, and Secretary
- Daniel Elgort, PhDChief Data and Analytics Officer
- Erik Karrer, PhDChief Scientific Officer
- Robert KimChief Medical Officer
- Cheng ZhangCEO, Co-Founder
- Will KrauseSVP, Finance
12 more named people on record for Character Biosciences, with roles, board committees and tenure — see the full roster →
Character Biosciences funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $8.9M | — | |
| Series B | $17M | 1 named | |
| SEC Form D filing | $48.2M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Hiring at Character Biosciences
Xcout recorded 1 job posting from Character Biosciences in the last 90 days, from a hiring record Xcout has kept since August 2026.
The weekly hiring trend, the roles and locations behind it — see Character Biosciences's hiring signals →
Top 12 Character Biosciences competitors
Ranked by semantic similarity — how close each company is to Character Biosciences by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotechnology
Beacon Therapeutics is a clinical-stage biotechnology company dedicated to saving and restoring sight for people living with rare and prevalent ocular diseases. The company works to deliver advanced retinal gene therapies to patients experiencing blindness.
Similar biotech company
Variant Bio, Inc. is a biotechnology company that uses human genomic diversity and population genetics to discover therapeutic targets and develop medicines. It works with researchers, healthcare and biotechnology partners, and genetically diverse communities to study traits associated with health and disease.
Similar biotech company
SpliceBio is a clinical-stage genetic medicines company that develops gene therapies using a proprietary Protein Splicing platform. The company focuses on treating diseases caused by mutations in large genes, with a lead clinical program targeting Stargardt disease.
Biotechnology
Ray Therapeutics, Inc. is a privately held optogenetic gene therapy company headquartered in Berkeley, California. The company focuses on reimagining vision through innovative genetic treatments and novel therapeutic solutions.
Biotechnology
SparingVision is a genomic and gene therapy medicines company translating pioneering science into vision-saving treatments, with US headquarters located in Boston, Massachusetts.
Similar biotech company
Adverum Biotechnologies is a clinical-stage biotechnology research company headquartered in Redwood City, California. The company focuses on developing novel gene therapies designed to redefine ocular care and treat severe eye diseases.
Biotechnology
Tyra Biosciences is a biotechnology company headquartered in Carlsbad, California, that develops next-generation precision medicines.
Similar biotech company
Addition Therapeutics is a biotechnology research company based in South San Francisco, California. The firm is on a mission to fulfill the promise of genomic medicine for chronic and rare diseases, having emerged from stealth with significant funding.
Biotechnology
Actio Biosciences is a privately held biotechnology company utilizing genomic medicine to discover and develop treatments for rare diseases and epilepsy.
Biotechnology
Coave Therapeutics is a clinical-stage biotechnology company headquartered in Paris, France. The company focuses on developing life-changing gene therapies targeting rare ocular and central nervous system diseases.
Biotechnology
Scenic Biotech is a biotechnology company headquartered in Amsterdam, Netherlands, that advances modifier therapy as an approach to treating genetic disorders by uncovering novel genome pathways.
Biotechnology
Eyevensys is a biotechnology company developing non-viral gene therapies for ophthalmic diseases. Its platform uses electro-transfection of the eye’s ciliary muscle to enable sustained local production of therapeutic proteins for retinal and other ocular conditions.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Character Biosciences and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Character Biosciencesand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →